Delay in treatment intensification increases the risks of cardiovascular events in patients with type 2 diabetes

Por Paul, Sanjoy K, Klein, Kerenaftali, Thorsted, Brian L, Wolden, Michael L, Khunti, Kamlesh
Publicado no Cardiovasc Diabetol (2015)

Use of Healthcare Services Following Severe Hypoglycemia in Patients with Diabetes: Analysis of Real-World Data

Por Goldstein, Dalit, Chodick, Gabriel, Shalev, Varda, Thorsted, Brian L., Elliott, Lisa, Karasik, Avraham
Publicado no Diabetes Ther (2016)

Use and effectiveness of a fixed‐ratio combination of insulin degludec/liraglutide (IDegLira) in a real‐world population with type 2 diabetes: Results from a European, multicentre,...

Por Price, Hermione, Blüher, Matthias, Prager, Rudolf, Phan, Tra‐Mi, Thorsted, Brian L., Schultes, Bernd
Publicado no Diabetes Obes Metab (2018)

Assessment of channeling bias among initiators of glucose-lowering drugs: A UK cohort study

Por Ankarfeldt, Mikkel Z, Thorsted, Brian L, Groenwold, Rolf HH, Adalsteinsson, Erpur, Ali, M Sanni, Klungel, Olaf H
Publicado no Clin Epidemiol (2017)

Self-reported hypoglycaemia in patients with type 2 diabetes treated with insulin in the Hoorn Diabetes Care System Cohort, the Netherlands: a prospective cohort study

Por Rauh, Simone P, Rutters, Femke, Thorsted, Brian L, Wolden, Michael L, Nijpels, Giel, van der Heijden, Amber A W A, Walraven, Iris, Elders, Petra J, Heymans, Martijn W, Dekker, Jacqueline M
Publicado no BMJ Open (2016)